diaziquone has been researched along with Leukemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balis, FM; Blaney, SM; Poplack, DG | 1 |
Dicke, KA; Spitzer, G | 1 |
Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ruccione, KS | 1 |
Davis, RB; Lee, EJ; Mayer, RJ; Peterson, BA; Schiffer, CA | 1 |
Egorin, MJ; Lee, EJ; Nayar, MS; Schiffer, CA; Shulman, P; Van Echo, DA | 1 |
Bachur, NR; Egorin, MJ; Fox, BM; Friedman, RD; Gutierrez, PL; Spiegel, JF | 1 |
Bachur, NR; Egorin, MJ; Fox, BM; Friedman, R; Gutierrez, PL | 1 |
1 review(s) available for diaziquone and Leukemia
Article | Year |
---|---|
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous | 1986 |
6 other study(ies) available for diaziquone and Leukemia
Article | Year |
---|---|
Pharmacologic approaches to the treatment of meningeal malignancy.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa | 1991 |
A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Leukemia; Male | 1988 |
Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Female; Humans; Leukemia; Male; Middle Aged | 1987 |
Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Female; Humans; Kinetics; Leukemia; Male; Middle Aged; Platelet Count; Recurrence | 1986 |
Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carbon Radioisotopes; Cell Division; Cell Line; Free Radicals; Humans; Leukemia; Mice; Oxygen Consumption; Thymidine; Uridine | 1985 |
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cell Line; Ethylmaleimide; Free Radicals; Humans; Kinetics; Leukemia; Leukemia L1210; Mice; NADP; Oxygen Consumption | 1985 |